CervoMed Inc.
CRVO
$2.73
-$0.20-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -95.74% | -77.56% | -58.86% | -38.81% | -19.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -95.74% | -77.56% | -58.86% | -38.81% | -19.44% |
| Cost of Revenue | -0.16% | -17.74% | -10.47% | 24.16% | 52.85% |
| Gross Profit | -78.97% | -30.61% | -41.53% | -165.00% | -494.46% |
| SG&A Expenses | -0.07% | 17.57% | 14.37% | 14.77% | 11.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.59% | 9.75% | 15.51% | 41.77% | 58.50% |
| Operating Income | -26.91% | -48.57% | -55.24% | -102.01% | -128.52% |
| Income Before Tax | -34.22% | -60.88% | -65.53% | -114.15% | -348.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.22% | -60.88% | -65.53% | -114.15% | -348.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.22% | -60.88% | -65.53% | -114.15% | -348.36% |
| EBIT | -26.91% | -48.57% | -55.24% | -102.01% | -128.52% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -24.54% | -52.38% | -49.27% | -79.55% | -543.67% |
| Normalized Basic EPS | -24.53% | -52.36% | -49.26% | -79.53% | -543.45% |
| EPS Diluted | -24.54% | -52.38% | -49.27% | -79.55% | -47.46% |
| Normalized Diluted EPS | -24.53% | -52.36% | -49.26% | -79.53% | -437.42% |
| Average Basic Shares Outstanding | 8.41% | 5.46% | 12.01% | 19.32% | 43.40% |
| Average Diluted Shares Outstanding | 8.41% | 5.46% | 12.01% | 19.32% | 40.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |